https://youtu.be/4lMp_363B2c

Filed under: General Problems | 5 Comments »

Medical marijuana legal in Ohio, but patients still can’t get it

http://www.dispatch.com/content/stories/local/2016/10/26/medicine-medical-marijuana-legal-but-patients-still-cant-get-it.html

Can you legally buy medical marijuana in Ohio?

If so, can you get it from a licensed medical marijuana dispensary, family member or friend, drug dealer or grow it yourself?

You would think the answers to these questions would be simple and straightforward under the letter of the law. Not so much.

Technically, medical marijuana has been legal in Ohio since a new law, House Bill 523, took effect Sept. 8.

But as of yet — and probably not until 2018 — patients in Ohio cannot legally buy marijuana for medical purposes.

Before that happens, the complicated, time-consuming job of drafting rules, policies, certifications, licenses and many other things must be completed. Rules don’t have to be in place, by law, until next year. Only after rules go through two state oversight agencies can cultivators begin growing marijuana crops, with processing, lab testing and sales through licensed dispensaries to follow.

That begs the question: Is it legal now?

The best answer to that came last week from the State Medical Board. Even then, it wasn’t a very good answer.

Advocates have pressed the board to allow physicians to utilize an “affirmative defense” clause in the statue, essentially offering legal protection against prosecution if physicians recommend medical marijuana for a patient prior to it being available here.

Robert Giacalone, a medical board member, said the agency “is in no way prohibiting the recommendation of medical marijuana now that HB523 is effective.” But he added there is “ conflicting language” in the law because of a provision prohibiting physicians from recommending marijuana until Ohio rules are written and the product is grown and sold in the state.

“If any physician wishes to recommend medical marijuana before the rules are in place, we strongly recommend that they contact a private attorney,” Giaclone said at a board meeting last Wednesday.

Rob Ryan, head of Ohio Patient Network, an advocacy group, said, “There is no doubt in my mind that people with qualifying conditions should be able to get medical marijuana in Ohio.”

Ryan said he knows some physicians are recommending marijuana but, like patients, they are being very cautious.

Asked where patients can get marijuana if they have a physician’s recommendation, Ryan said, “it might be growing in your backyard or basement, from a family member or friend, or a dealer as a last resort. I’d be very careful going out of state.”

Attorney General Mike DeWine’s office, which advises the medical board, concludes it would be “ very difficult” to legally obtain marijuana in Ohio at this time.

“Everybody knows there’s significant lead time built into this statute,” DeWine spokesman Dan Tierney said. “We don’t have the specific rules in place at the medical board or the pharmacy board.”

Ohio will not permit smoking marijuana for medical purposes. Alternatives are vaping, oils, patches and edibles.

Officials with the Ohio Commerce Department, which will oversee and license cultivators, processors and testing labs, and the Ohio Board of Pharmacy, which is in charge of dispensaries and a patient registry, said they are working on draft rules to be released later this year.

The rules will have to be reviewed by the Common Sense Initiative panel, which looks at the impact of government regulation on business, and the Joint Committee on Agency Rule Review, a legislative body that considers rules enacted by state agencies.

Another potential hurdle being put up by dozens of communities statewide are moratoriums on medical marijuana dispensaries. The moratoriums range from six months in New Albany, Pickerington, Springfield and 40 other cities to 18 months in Bexley, and a permanent ban in Hamilton in Butler County.

The delays and moratoriums are seen as chipping away at the law by Savannah Smith of the Ohio Rights Group, an advocacy organization.

“It’s extremely frustrating,” Smith said. “The sick, dying and disabled of Ohio are our most vulnerable. They are medical refugees.

“We had hoped this law would provide some real relief for the population that we’ve been fighting for for years.”

Filed under: General Problems | 4 Comments »

Drug maker thwarted plan to limit OxyContin prescriptions at dawn of opioid epidemic

www.statnews.com/2016/10/26/oxycontin-maker-thwarted-limits/

ELCH, W.Va. — The warning signs of what would become a deadly opioid epidemic emerged in early 2001. That’s when officials of the state employee health plan in West Virginia noticed a surge in deaths attributed to oxycodone, the active ingredient in the painkiller OxyContin.

They quickly decided to do something about it: OxyContin prescriptions would require prior authorization. It was a way to ensure that only people who genuinely needed the painkiller could get it and that people abusing opioids could not.

But an investigation by STAT has found that Purdue Pharma, the manufacturer of OxyContin, thwarted the state’s plan by paying a middleman, known as a pharmacy benefits manager, to prevent insurers from limiting prescriptions of  the drug.

The financial quid pro quo between the painkiller maker and the pharmacy benefits manager, Merck Medco, came to light in West Virginia court records unsealed by a state judge at the request of STAT, and in interviews with people familiar with the arrangement.

“We were screaming at the wall,” said Tom Susman, who headed the state’s public employee insurance agency in the early 2000s and led the push to limit OxyContin prescribing in West Virginia.

“We saw it coming,” he said of the opioid epidemic, which today causes 28,000 overdose deaths a year in the United States. “Now to see the aftermath is the most frustrating thing I have ever seen.”

Overprescribing of OxyContin and other opioid painkillers is blamed for helping to plant the seeds for the current opioid crisis. West Virginia has been hit harder than any other state: It suffers the highest per capita drug overdose death rate in the country — more than double the national average. It also has one of the highest rates of painkiller prescribing.

In McDowell County, where the court records from a state lawsuit against Purdue were unsealed, the local sheriff said prescription pill abuse is so rampant that the county plans to file a new lawsuit against painkiller makers.

The strategy to pay Merck Medco extended to other big pharmacy benefit managers and to many other states, according to a former Purdue official responsible for ensuring favorable treatment for OxyContin. The payments were in the form of “rebates” paid by Purdue to the companies. In return, the pharmacy benefit managers agreed to make the drug available without prior authorization and with low copayments.

Filed under: General Problems | 1 Comment »

AT&T earns millions selling call data to law enforcement without court order

http://www.phonearena.com/news/AT-T-earns-millions-selling-call-data-to-law-enforcement-without-court-order_id87067

When it comes to call info sweeps, nothing beats the NSA, one might think, but they would be wrong. Back in 2013, the New York Times discovered that the DEA – you know, the department in charge of the “war on drugs” – appears to have logged billions of AT&T call records, in fact a 26-year amount, and counting. Dubbed Project Hemisphere, the undertaking lifted off in 2007, and has apparently never looked back.

We are talking here about actual AT&T personnel sitting in DEA’s offices, helping with the data collection and assisting with, say, tracking those “burner” phones drug dealers use, says the Sunday Times. The report was based on a 27-slide PowerPoint presentation by the DEA, meant for law enforcement officials. The government is apparently chipping in for the expenses connected with all that snooping that goes back to phone records from 1987, and includes every call that has ever passed through the AT&T network, including from other carriers.

This is a pretty dangerous precedent, and AT&T has the incentive to keep the scheme going. After all, municipalities are paying well for using Hemisphere, from $100 thousand to more than a million a year, so why ruin a good thing with extra privacy precautions. The money then get reimbursed through that same police militarization program that supplies Iraq insurgency level equipment to local police departments, so ultimately it’s the taxpayer covering the costs on their own court order-less snooping.

Filed under: General Problems | Leave a Comment »

Filed under: General Problems | Leave a Comment »

FDA’s Opioids Action Plan: A Midyear Checkup

http://blogs.fda.gov/fdavoice/index.php/2016/10/fdas-opioids-action-plan-a-midyear-checkup/

By: Robert M. Califf, M.D.

As FDA works to address the opioid epidemic of abuse, misuse and addiction, it’s valuable to see firsthand some of the ways the crisis is affecting our communities.

This summer, I toured areas hard-hit by the opioid crisis in Tennessee, West Virginia, and Kentucky, visiting  with survivors of opioid addiction and overdose as well as community activists, government officials, and health care providers, all of whom are working diligently and creatively to address and overcome this crisis.

My visit to the nationally-recognized neonatal intensive care unit at East Tennessee Children’s Hospital was deeply moving and set the stage for the rest of my tour and underscored the urgency of fighting this epidemic. More than a third of the babies admitted to the NICU have neonatal opioid withdrawal syndrome (NOWS), a condition which can be life-threatening if not recognized and treated

Watching a nurse treat a fretful baby suffering from NOWS underscored the complexity of the opioid problem.  Many women taking opioids haven’t planned their pregnancy, don’t immediately know they are pregnant and may not be aware of the risk that opioids pose to their unborn child. This includes those women who are taking medication as part of medication-assisted treatment (MAT) which also includes counseling and behavioral therapies. For women on MAT, the risk of NOWS must be balanced against the additional dangers of untreated opioid addiction during pregnancy.

How best to prevent NOWS and treat opioids use disorder was a continued theme of my trip, and among the issues we grappled with during a roundtable at the University of Tennessee’s Medical Center hosted by Surgeon General Vivek Murthy, who is traveling the country to discuss solutions to opioid abuse as part of his TurnTheTideRx campaign. I’m pleased that expanding access to and the use of evidence-based MAT is a key focus area for the Administration, is a part of the HHS-wide opioid initiative, and is an approach supported by a recent FDA advisory committee.

In Charleston, WV, I met with several patients who are reclaiming their lives with the use of MAT including “Dave.” Like so many others, Dave became addicted to opioid pain medication after being treated for an injury. As a result of his addiction, his marriage failed and he lost contact with his children. But with treatment, he has reunited with his family and next spring will graduate from college and hopes to taper off of his treatment.

Throughout my tour, I heard that opioid education – including training during medical school and residency and greater public awareness far and wide – is a key component in fighting the opioid epidemic. At a roundtable in Charleston, Gov. Earl Ray Tomblin and U.S. Sen. Joe Manchin singled out their state’s model mandatory education program for prescribers and they told me the state is leading an effort to implement the CDC’s Guideline for Prescribing Opioids for Chronic Pain as a best practice for their state-run Medicaid program.

At a firehouse in the town of Williamson, WV, I met with those on the frontlines of the opioid epidemic – the firefighters and first responders who carry life-saving naloxone to help reverse an overdose. They told me more education about naloxone was needed and told me that they appreciate our efforts to help make naloxone more available to the general public.

My last stop this summer was to Kentucky where I toured the emergency room at the Pikeville Medical Center and participated in a roundtable with physicians, pharmacists, and state policy and community leaders brought together with the help of the regional organization Operation UNITE. UNITE coordinates treatment for those with substance use disorder as well as support for their families and friends, and educates the public about the dangers of drug use. These measures, combined with a recent state law requiring prescribers to register with a prescription drug monitoring program are working, we were told.

Throughout my travels, I listened and learned more about how FDA can help end this crisis. I also had the chance to share what FDA has been doing this year to implement a multipart plan to address the opioid epidemic.

Our milestones so far include:

• Developing warning and safety information for immediate release opioids and requiring that prescription opioid analgesics and opioid-containing cough product labels include strengthened warnings about the risk of using benzodiazepines at the same time.
• Working to better understand the long-term safety of using extended release/long acting opioids. Sponsors must now conduct a number of studies to generate postmarket data on these products.
• Issuing draft guidance for industry to support the development of generic versions of approved opioids with abuse-deterrent formulations.
• Seeking advice from the National Academy of Science Engineering and Medicine on how to balance both the needs of patients with pain and the need to address opioid misuse and abuse.
• Supporting increased access to naloxone; for instance, by awarding a contract to conduct consumer behavior studies based on model product labeling for a potential OTC version of the antidote and by launching a competition to create a mobile app that could help find the closest available naloxone treatment in an emergency.
• Approving the first implantable treatment for the maintenance treatment of opioid dependence.

The community-based successes I observed on my three-state tour reinforced my view that we are making important progress in addressing this crisis.  But continued hard work, creative ideas, and collaboration — across government, with the medical profession, health care providers, industry, and, most importantly, patients and their families, is still required.

We at FDA will continue to work with all of these groups, using all the resources at our disposal, to improve the judicious and responsible use of opioids and to help bring an end to this epidemic.

Robert M. Califf, M.D., is Commissioner of the U.S. Food and Drug Administration

Filed under: General Problems | 2 Comments »

Montgomery pharmacist facing malpractice suit

MONTGOMERY, AL (WSFA) –

A Montgomery pharmacist is facing legal action for allegedly revealing her customers’ private information.

The Alabama State Board of Pharmacy has also taken action against pharmacist Dee Parks.

According to court documents, Parks is the focus of a civil malpractice suit for allegedly giving patient information to a third party.

Attorney Virginia Lucci says Parks issued a lease to one of Lucci’s client. On the back of the lease were three dozen patients of Parks Pharmacy, along with their prescription information, doctor’s name and doctor’s number.

Lucci says it appears Parks decided to print the lease on the blank side of a paper that had been used for her pharmacy’s dispensing report log.

“The HIPAA law was created so that people wouldn’t know what kind of medication you are on. It’s an invasion of privacy,” Lucci said.

In the wrong hands, Lucci believes more than just HIPAA laws could have been violated. She says many of the prescriptions are controlled substances like hydrocodone.

“That information out there, it’s real easy to track these folks down. A lot of these people are older and could become targets for crime to steal their medication,” Lucci said.

Emily Nichols with the Attorney General’s Office says although personal information that can be used in identity theft, like social security numbers, wasn’t compromised, this still should serve as a reminder to be more careful.

“Keep an eye on things like our credit reports, credit card statements, prescriptions. Make sure when we go to the pharmacy to pick up a prescription, there’s not multiple prescriptions in our name. If you are there to pick up one and they say there is two here, find out why there is two there in your name. Be sure to ask questions,” Nichols said. “So many people are hesitant or shy about asking questions and being up front about their own identity and their information. There is no reason that you need to be shy about asking questions.”

We reached out to Parks for a comment, and she said she is waiting for her day in court.

After several violations from a different case, including operating a pharmacy without a permit, not having a valid DEA registration and State Controlled Substances registration, storing drugs in a warehouse and not in a pharmacy, the State Board of Pharmacy suspended Parks license to practice pharmacy and state controlled substance permit for five years.

One more reminder when it comes to protecting your personal information, the Attorney General’s Office advises you never to leave your mail sitting out in public view and invest in a shredder to destroy documents that you might have otherwise just tossed into the trash. 

Filed under: General Problems | Leave a Comment »

Feds: Most states to see steep ObamaCare rate hikes

http://thehill.com/policy/healthcare/302569-feds-most-states-to-see-steep-obamacare-rate-hikes

Filed under: General Problems | Leave a Comment »

Obama Floods US with Opioids; Kills DEA Enforcement Program

https://larouchepac.com/20161025/obama-floods-us-opioids-kills-dea-enforcement-program

Looks like all of these attorneys from Obama/Holder on down… are more interested in job security for the DEA than anything else. Remember, Holder left office being held in contempt of Congress… there has been THREE MEMBERS of the Obama administration and/or affiliated with the Democratic Party/Clinton https://en.wikipedia.org/wiki/Contempt_of_Congress  that still have the charge of CONTEMPT OF CONGRESS  against them and no legal actions taken against them.

But the information in this article along with what we know about all those chronic pain pts having their opiates cut back or discontinued and/or their prescribers being charged with fabricated charges and hundreds or thousands of pts being “thrown to the street”.. and some have committed suicide or started using “street drugs”… and now we have so many ODing because of Acetyl Fentanyl or Carfentanyl being mixed with street Heroin and the DEA does not seem to be capable of stop the importing of these very lethal drugs into our country and on to our streets.

If you read/listen to all the DEA press releases it FOCUSES on all the OD DEATHS… which it seems that they may be the root cause of people being forced to turn to “street drugs” ?

Filed under: General Problems | 4 Comments »

Insurance Company Would Rather Stephanie Packer Die Than Pay For Her Cancer Treatment

thefederalistpapers.org/us/insurance-company-would-rather-stephanie-packer-die-than-pay-for-her-cancer-treatment

This is what leftist medicine has wrought:

A terminally ill woman in California had coverage for her chemotherapy treatment denied by her insurance company, but they’ll gladly pay for her to commit suicide.

The new California law permits physician-assisted suicide, and as a result, it appears that insurance companies have found a great cost-saving measure: kill their sickest patients.

Stephanie Packer, a wife with four children, was diagnosed with a terminal form of scleroderma. She said her insurance company initially told her it would cover but switching to a different chemotherapy drug at the advice of her doctors, The Washington Times is reporting.

For a while, five months or so, we’ve been trying to get me on a different chemotherapy drug for the infusions, because my doctor felt that it would be less toxic than some of the other drugs that we were going to be using,” Ms. Packer said in a video distributed by The Center for Bioethics and Culture Network on Monday.

But shortly after California’s “End of Life Option Act” went into effect – authorizing doctors to diagnose a fatal dose of medication with a prognosis of six months or less to live, Packer’s insurance company quickly reversed themselves and denied the request:

“And when the law was passed, it was a week later I received a letter in the mail saying they were going to deny coverage for the chemotherapy that we were asking for,” Ms. Packer said.

She said she called her insurance company to find out why her coverage had been denied. On the call, she also asked whether suicide pills were covered under her plan.

“And she says, ‘Yes, we do provide that to our patients, and you would only have to pay $1.20 for the medication,’” Packer said.

All of this comes as other states and areas are considering their own “assisted suicide” bills. Oregon has a “Death with Dignity” act, and the D.C. City council is considering permitting physician-assisted suicide.

After the right-to-die movement began garnering national attention, Ms. Packer said she noticed a change in tone at her support groups for terminally ill patients. While the meetings were formerly positive and encouraging, she said the specter of suicide now hangs above them like a dark cloud.

“And people, once they became depressed, it became negative, and it started consuming people,” she said in the video. “And then they said, ‘You know what? I wish I could just end it.’”

Filed under: General Problems | 5 Comments »